Intravenous metoclopramide induced generalized multifocal myoclonus

Opsoclonus-myoclonus-ataxia syndrome (OMAS) is an autoimmune disorder involving the nervous system characterized by rapid involuntary eye movements (opsoclonus), involuntary brief muscle twitching (myoclonus), loss of coordination of movements, imbalance, disturbances of sleep, irritability, slurring of speech, and decreases muscle tone. Hyperemesis gravidarum, intractable vomiting during pregnancy, results in reduction in intravascular volume, can produce ketonemia. We describe a case of primigravida who had hyperemesis gravidarum and suffered metoclopramide-induced OMAS.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Intravenous metoclopramide induced generalized multifocal myoclonus

Cited by 2 publications

References 2 publications

Metoclopramide

Metoclopramide

Metoclopramide-induced opsoclonus-myoclonus-ataxia syndrome: A rare side-effect

Contact Info

Product

Resources

About